All Pharma News
price-trendAsk Us
ReNeuron lays off 40% of staff to buy time for exosome pivot

ReNeuron lays off 40% of staff to buy time for exosome pivot
Nick Paul Taylor FIERCE BIOTECH
19 Jan 2023
Share Share
ReNeuron: Catherine Isted appointed as CEO

ReNeuron: Catherine Isted appointed as CEO
RTTNEWS
01 Aug 2022
Share Share
Director Change

Director Change
RENEURON
11 Feb 2022
Share Share
First subject treated at Oxford Eye Hospital in Phase 2a RP trial

First subject treated at Oxford Eye Hospital in Phase 2a RP trial
RENEURON
18 Oct 2021
Share Share
ReNeuron Announces Further Positive Data in Retinal Clinical Trial

ReNeuron Announces Further Positive Data in Retinal Clinical Trial
PRNEWSWIRE
29 Jun 2020
Share Share
ReNeuron Announces CTX Cell Line Shows Further Potential

ReNeuron Announces CTX Cell Line Shows Further Potential
PRNEWSWIRE
07 May 2020
Share Share
ReNeuron Announces Exosome Research Collaboration

ReNeuron Announces Exosome Research Collaboration
PR NEWSWIRE
07 Apr 2020
Share Share